Senior Coordinator, QC Sample |
Durham |
USA |
Operations |
Innovative Medicines |
Quality |
1月 05, 2025 |
Manager, Global Program Regulatory Manager (GPRM) Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
1月 05, 2025 |
Technical Trainer |
Morris Plains |
USA |
Operations |
Innovative Medicines |
Technical Operations |
1月 05, 2025 |
Facilities Mechanic (Jr.-Sr. level) |
Morris Plains |
USA |
Operations |
Innovative Medicines |
Facilities & Administration |
1月 05, 2025 |
Bioprocess Technician/Engineer (Upstream Nights) |
Durham |
USA |
Operations |
Innovative Medicines |
Technical Operations |
1月 05, 2025 |
QA Associate |
Morris Plains |
USA |
Operations |
Innovative Medicines |
Quality |
1月 05, 2025 |
Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
BU Field Training & Development Head |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
Area Training Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
Non Drug Program Associate Director |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
1月 05, 2025 |
Analyst-Quality Operations |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Quality |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
Assistant Manager – Financial Compliance Standards & Governance |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
1月 05, 2025 |
(高级)地区经理 |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
Assoc. Director- Solutions Delivery (SAP Business Process Automation) |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
1月 05, 2025 |
Associate Director AWS D&A Platform Analytics |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
1月 05, 2025 |
Analitik (m/ž/d) / FRA Analyst (m/f/d) |
Ljubljana |
Slovenia |
Finance |
CTS |
Audit & Finance |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
Japan Program Manager |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Yichang (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Huhehaote (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Zhengzhou (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
县域主任/县域主管 |
Suining (Sichuan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Bijie (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
MR Intern |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Others |
1月 05, 2025 |
(高级)医药代表 /(资深)产品专员 |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
1月 05, 2025 |
(高级)地区经理 |
Nanning (Guangxi Province) |
China |
International |
Innovative Medicines |
Sales |
1月 04, 2025 |
(Sr.) Launch Excellence Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Marketing |
1月 04, 2025 |
(高级)大区经理 |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
1月 04, 2025 |
(高级)大区经理 |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
1月 04, 2025 |
(高级)医药代表 /(资深)产品专员 |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 04, 2025 |
(高级)医药代表 /(资深)产品专员 |
Changsha (Hunan Province) |
China |
International |
Innovative Medicines |
Sales |
1月 04, 2025 |
Travel and Expenses Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
1月 03, 2025 |
Medical Manager |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
1月 03, 2025 |
Associate Director, DDIT US&I Analytics Operations Service Delivery |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
1月 03, 2025 |
Commercial & Pricing Associate |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
1月 03, 2025 |
Associate Director, DDIT US&I Data Architect |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
1月 03, 2025 |
Assoc. Dir. DDIT Strategy and Growth Solution Delivery |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
1月 03, 2025 |
Associate Director, R&D Executive Communications and Storytelling |
Cambridge (USA) |
USA |
Corporate Affairs |
CTS |
Communications & Public Affairs |
1月 03, 2025 |